Image (Cc039b2c 1602 4311 B976 9125434bc152 01)
Topiramate Capsule, Extended Release
Product Images NDC 70748-277
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70748-277). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Cc039b2c 1602 4311 B976 9125434bc152 02)
This text provides information on cumulative rates for time to first seizure, comparing the effectiveness of Topiramate at 50 mg/day and 400 mg/day dosages. The data demonstrates a comparison over time, possibly indicating the duration until the first seizure occurrence.*
Image (Cc039b2c 1602 4311 B976 9125434bc152 03)
This text appears to contain information related to medications, specifically mentioning "Topiramate", "100mg", and "20". It might be a prescription or dosage instruction for a medication containing Topiramate in specific quantities. The text also includes references to numbers and symbols such as "<", "*", and "p0.001" that could provide additional medical information.*
Topiramate Extended-release Capsules Usp, 25 mg30 Capsules Ndc 70748-275-06 (Cc039b2c 1602 4311 B976 9125434bc152 04)
Topiramate Extended-release Capsules, 50 mg30 Capsules Ndc 70748-276-06 (Cc039b2c 1602 4311 B976 9125434bc152 05)
This is a description of a medication with the National Drug Code NDC 70748-276-06. It is recommended to take it once daily, swallow the capsule whole and intact, and store it at a temperature range of 15°C to 30°C (59°F to 86°F) to protect it from moisture and light. It is crucial to keep this medication out of reach of children. The medication appears to be produced in Sambhajinagar, India.*
Topiramate Extended-release Capsules, 100 mg30 Capsules Ndc 70748-277-06 (Cc039b2c 1602 4311 B976 9125434bc152 06)
Topiramate Extended-release Capsules, 200 mg30 Capsules Ndc 70748-278-06 (Cc039b2c 1602 4311 B976 9125434bc152 07)
This text provides information about a medication called Topiramate 200mg in capsule form. It includes details on how to take the medication, storage instructions, warnings about not opening or crushing the capsule, and the manufacturer (Lupin Pharmaceuticals, Inc.). The text also mentions the dosage, prescribing information, and contact details for Lupin Pharmaceuticals.*
Image (Cc039b2c 1602 4311 B976 9125434bc152 294 1)
Image (Cc039b2c 1602 4311 B976 9125434bc152 318 2)
This text mentions that "LUPIN" and "A" are registered trademarks of Lupin Pharmaceuticals. These trademarks are likely associated with products or services provided by Lupin Pharmaceuticals.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
